Top News
Vistusertib Provides No Benefit in Platinum-Resistant/Refractory Ovarian Cancer
Survival Improving in Metastatic Bladder Cancer
Postoperative AEs Delay Chemotherapy but Do Not Affect Survival in Ovarian Cancer
Tafinlar Plus Mekinist Approved for Pediatric BRAF V600E Low-Grade Glioma
US Proposes Reducing PFAS in Drinking Water
Clinical Trial: Adding Vorinostat to Pembrolizumab and Tamoxifen in ER+ Breast Cancer
Clinical Trial: Valemetostat Plus Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer
Clinical Trial: Tucatinib Plus Alpelisib in PIK3CA-Mutant, HER2+ Breast Cancer
Clinical Trial: CAR-T Cells in Mesothelin-Expressing Triple-Negative Breast Cancer
Robust Breast Cancer Patients Have Higher Risk of Worsening Frailty Status
Surgery, Radiation Therapy Offer Similar Survival in High-Risk Prostate Cancer
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
The Cost of Bladder Cancer Care Is Rising. Could Value-Based Care Models Help?
The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief. -
ctDNA Testing in Colorectal Cancer Deemed Promising but Not Ready for Prime Time
Studies suggest that ctDNA testing has prognostic value in colorectal cancer, but more research is needed before it can be used in practice. -
Preventing and Treating COVID-19 in Cancer Patients: Challenges in the Omicron Era
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus. -
Cardiovascular Risk Stratification for Older Adults Undergoing Cancer Surgery
Identifying limitations in functional reserves in the older adult leads to improved decision-making related to cardiovascular risk stratification and elective procedures. -
Sexual Health and Cancer: What Providers Need to Know
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked. -
ASCO GU 2023
News from the ASCO Genitourinary Cancers Symposium -
Patient Portals in Oncology: Helpful or Harmful?
Studies and anecdotal reports suggest patient portals can be both beneficial and detrimental for oncology patients and providers. -
Cancer Patients May Fall Prey to Illegitimate Online Pharmacies
High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies. -
Aggregating Data Hides Cancer Disparities Affecting Asian and NHPI Patients in the US
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
More Features
ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline
Improving End-of-Life Discussions With Cancer Patients
ASH 2022: MCL Trials Break New Ground, May Change Practice
ASH 2022: Promising Results in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma
AML Research From ASH 2022: Novel Combinations and Evidence That “Less is More”
- Loading...
Loading...
Loading... 
Loading...